HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20...

14
HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE EFSA Focal Point Oslo, 18 th April Dr Anusha Panjwani, FSA London

Transcript of HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20...

Page 1: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

HEPATITIS E VIRUS WORKSHOP IN POLICY

AND SCIENCE

EFSA Focal Point

Oslo, 18th April

Dr Anusha Panjwani, FSA London

Page 2: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Van der Poel, 2014

(Potential) reservoirs

Potential transmission routes

Page 3: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

HEV surveillance systems in EU/EEA, 2015

20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Page 4: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Significant gaps in our understanding:

• These gaps both in science have contributed to the lack of clear

risk intervention strategies/ policy decisions

5

Page 5: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Hepatitis E virus workshop in Policy and Science, Amsterdam

8

Farm and Environment

Processing Human

Consumption

Page 6: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Workshop Outputs:

9

• Promote scientific cooperation by identifying and plugging evidence

gaps, collaboration on ongoing or future research activities within the

theme.

• Act as a platform to inform policy interventions at a high level to

discuss and agree on a policy plan to mitigate any risk to health.

• Encourage intelligence sharing between MS with the aim of building

networks of communication and collaboration between policy/decision

makers and scientists ultimately making the decision-making process

more efficient. ----------In principle agreements-----------

Page 7: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Is HEV seen as a serious public health risk? Use the relative scale from 1(negligible) to 5 (very serious)

Scale 1: 2

Scale 2: 6

Scale 3: 7

Scale 4: 2

Scale 5: 0

Page 8: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

HEV incidence in pigs and wildlife, humans and pork products

12

YES: 10 NO: 7 YES: 9 NO: 8

YES: 13 NO: 4

Page 9: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Breakout discussion – Priority measures

Identified up to three priority measures at all 3 levels:

• What are the gaps in our understanding of HEV that pose

challenges for ongoing or future effectiveness of each measure?

• Is the measure achievable in the short-term or long-term? What is

the estimated timeframe over which this measure could be introduced

in your view?

• Once the three selected measures have been discussed, rank the

measures in order of priority for your group (1-3).

13

Page 10: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Consensus on priorities for addressing HEV

1. Effective on-farm interventions

2. Achieve inactivation in high-risk products

3. Reduce human exposure

14

Page 11: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Breakout discussion - Objectives

For each objective please consider:

• What actions are required to achieve this objective?

• What resources are required to achieve this?

• Who needs to be involved? (consider national, regional and

international levels)

15

Page 12: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

1. Monitoring and surveillance

2. Risk profiling of products

3. Targeted advice

16

Voting and Consensus on objectives for addressing HEV

Voting

Page 13: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

Next Steps

• Report (Target June 2018)

• National and international consortia including

gathering industry support to test the application of

potential policy interventions

17

Page 14: HEPATITIS E VIRUS WORKSHOP IN POLICY AND SCIENCE · HEV surveillance systems in EU/EEA, 2015 20 EU/EEA countries with HEV-specific surveillance Ref: ECDC

18